Clinical Trials for Lymphoma

Cognitive Aftereffects of Neurotoxicity in Children and Young Adults With Relapsed/Refractory Hematologic Malignancies Who Receive CAR T-cell Therapy

NCT ID: NCT05237986

This clinical trial is looking at how CAR T-cell therapy, a new treatment for blood cancers like leukemia and lymphoma, may affect thinking and memory in children and young adults between the ages ...

Natural History Study to Determine Drug Metabolism Phenotype and Appropriate Germline Source DNA in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplant

NCT ID: NCT06856226

This clinical trial is studying how our genes affect how medications are processed in patients who receive a special treatment called allogeneic hematopoietic stem cell transplant (HSCT). After thi...

Nivolumab in Epstein-Barr Virus (EBV)-Positive Lymphoproliferative Disorders and EBV-Positive Non-HodgkinLymphomas

NCT ID: NCT03258567

This clinical trial is studying a drug called Nivolumab to see if it can help slow down or stop the growth of certain cancers related to the Epstein-Barr Virus (EBV), specifically EBV-positive lymp...

Vaccine Responses in Patients With B Cell Malignancies

NCT ID: NCT05170399

This clinical trial is looking at how well vaccines work for patients with certain types of blood cancers known as B cell malignancies, such as chronic lymphocytic leukemia (CLL) and lymphoma. Many...

GSL Synthetase Inhibitor Eliglustat Combined With CD30 Target Immunotherapy for the Treatment of of CD30+ Lymphoma

NCT ID: NCT07138547

This clinical trial is studying a new treatment approach for a type of cancer called CD30-positive lymphoma, which means the cancer cells have a specific marker called CD30. The study is testing wh...

Neuromodulation of Cardiovascular Risks Associated With Cardiotoxic Chemotherapy

NCT ID: NCT05921253

This clinical trial is exploring whether a treatment called low-level vagus nerve stimulation can help improve heart health in people with breast cancer or lymphoma who have recently received certa...

A Study of Epcoritamab With Lenalidomide and Tafasitamab in People With Diffuse Large B Cell Lymphoma

NCT ID: NCT07030699

This clinical trial is studying a new combination of medicines—epcoritamab, tafasitamab, and lenalidomide—to treat people with a type of blood cancer called diffuse large B-cell lymphoma (DLBCL) th...

Mosunetuzumab for CLL MRD Clearance

NCT ID: NCT07052695

This clinical trial is studying a new treatment called mosunetuzumab, either by itself or combined with drugs known as BTK inhibitors, for people with chronic lymphocytic leukemia (CLL) or small ly...

A Study of Mosunetuzumab Alone or With Zanubrutinib in People With Follicular Lymphoma

NCT ID: NCT05389293

This clinical trial is studying a new treatment called mosunetuzumab for people with follicular lymphoma, a type of cancer that affects the lymphatic system, and who have recently been diagnosed bu...

Rituximab Plus Venetoclax in Front Line Marginal Zone Lymphoma

NCT ID: NCT06510309

This clinical trial is looking at whether a combination of two medications, rituximab and venetoclax, can effectively treat people with untreated Marginal Zone Lymphoma (MZL), a type of cancer. The...

Epcoritamab in Patients With Follicular Lymphoma Not Accomplishing a CR With Upfront Chemoimmunotherapy

NCT ID: NCT06510361

This clinical trial is studying a new treatment called epcoritamab for patients with follicular lymphoma who did not achieve complete remission after their initial chemotherapy and antibody treatme...

Odronextamab in Low Tumor Volume Advanced FL

NCT ID: NCT07128641

This clinical trial is studying a new treatment called odronextamab for people who have been newly diagnosed with follicular lymphoma, a type of slow-growing blood cancer that affects the lymph nod...

A Safety, Pharmacokinetic and Clinical Activity Study of NUC-7738 in Patients With Advanced Solid Tumours and Lymphoma

NCT ID: NCT03829254

This clinical trial is studying a new treatment called NUC-7738 for patients with advanced cancers, including solid tumors and lymphoma. The trial is divided into two phases. In the first phase, re...

Leukapheresis for CAR or Adoptive Cell Therapy Manufacturing

NCT ID: NCT03226704

CD30biAb-AATC for CD30+ Malignancies

NCT ID: NCT05544968

This clinical trial is studying a new type of treatment called CD30biAb-AATC, which is an immunotherapy designed for patients with certain types of cancers, including Hodgkin Disease and various fo...

A Study to Evaluate the Safety and Pharmacokinetics of Eflapegrastim in Pediatric Participants With Solid Tumors or Lymphomas and Treated With Myelosuppressive Chemotherapy

NCT ID: NCT04570423

This clinical trial is studying a medication called eflapegrastim to see how safe it is and how it works in children who have solid tumors or lymphomas and are receiving chemotherapy that can lower...

Serum Histone Succinylation as a Novel Prognostic Biomarker in Hematological Malignancies

NCT ID: NCT07131449

This clinical trial is studying whether a specific blood marker called serum histone succinylation can help doctors better predict how patients with blood cancers—like leukemia and lymphoma—will re...

A Study Evaluating the Safety and Efficacy of Glofitamab + Gemcitabine + Oxaliplatin in U.S. Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma

NCT ID: NCT06624085

This clinical trial is investigating a new treatment combination of three medications: glofitamab, gemcitabine, and oxaliplatin, for patients with a type of blood cancer called diffuse large B-cell...

Feasibility of Intermittent Fasting During Chemotherapy

NCT ID: NCT06645093

This clinical trial is exploring whether intermittent fasting—meaning not eating for certain periods before and after chemotherapy—is safe and acceptable for patients with Hodgkin lymphoma or Diffu...

Collection of Blood From Patients With Cancer, Other Tumors, or Tumor Predisposition Syndromes for Genetic Analysis

NCT ID: NCT01441089

This clinical trial is studying how certain genes may affect the way people with cancer respond to treatment. Researchers believe that some genes can influence the side effects of treatment and how...